311 related articles for article (PubMed ID: 30636733)
1. Memantine and Acetylcholinesterase Inhibitor Use in Alzheimer's Disease Clinical Trials: Potential for Confounding by Indication.
Huisa BN; Thomas RG; Jin S; Oltersdorf T; Taylor C; Feldman HH
J Alzheimers Dis; 2019; 67(2):707-713. PubMed ID: 30636733
[TBL] [Abstract][Full Text] [Related]
2. A clinical study of lupron depot in the treatment of women with Alzheimer's disease: preservation of cognitive function in patients taking an acetylcholinesterase inhibitor and treated with high dose lupron over 48 weeks.
Bowen RL; Perry G; Xiong C; Smith MA; Atwood CS
J Alzheimers Dis; 2015; 44(2):549-60. PubMed ID: 25310993
[TBL] [Abstract][Full Text] [Related]
3. Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial.
Porsteinsson AP; Grossberg GT; Mintzer J; Olin JT;
Curr Alzheimer Res; 2008 Feb; 5(1):83-9. PubMed ID: 18288936
[TBL] [Abstract][Full Text] [Related]
4. The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.
Gareri P; Castagna A; Cotroneo AM; Putignano D; Conforti R; Santamaria F; Marino S; Putignano S
J Alzheimers Dis; 2017; 56(2):557-565. PubMed ID: 28035929
[TBL] [Abstract][Full Text] [Related]
5. Retrospective study on the benefits of combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: the MEMAGE study.
Gareri P; Putignano D; Castagna A; Cotroneo AM; De Palo G; Fabbo A; Forgione L; Giacummo A; Lacava R; Marino S; Simone M; Zurlo A; Putignano S
J Alzheimers Dis; 2014; 41(2):633-40. PubMed ID: 24643135
[TBL] [Abstract][Full Text] [Related]
6. Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials: A Meta-analysis.
Kennedy RE; Cutter GR; Fowler ME; Schneider LS
JAMA Netw Open; 2018 Nov; 1(7):e184080. PubMed ID: 30646339
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease.
Wilkinson D; Andersen HF
Dement Geriatr Cogn Disord; 2007; 24(2):138-45. PubMed ID: 17622761
[TBL] [Abstract][Full Text] [Related]
8. Trends in the Prescription and Long-Term Utilization of Antidementia Drugs Among Patients with Alzheimer's Disease in Spain: A Cohort Study Using the Registry of Dementias of Girona.
Calvó-Perxas L; Turró-Garriga O; Vilalta-Franch J; Lozano-Gallego M; de Eugenio R; Márquez F; Carmona O; Gich J; Manzano A; Viñas M; Roig AM; Garre-Olmo J;
Drugs Aging; 2017 Apr; 34(4):303-310. PubMed ID: 28258538
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication.
Yang YH; Wu MN; Chou PS; Su HC; Lin SH; Sung PS
Curr Alzheimer Res; 2018 Mar; 15(5):474-481. PubMed ID: 29032750
[TBL] [Abstract][Full Text] [Related]
10. Monotherapy Is Good Enough for Patients with Mild-to-Moderate Alzheimer's Disease: A Network Meta-analysis of 76 Randomized Controlled Trials.
Tsoi KK; Chan JY; Chan FC; Hirai HW; Kwok TC; Wong SY
Clin Pharmacol Ther; 2019 Jan; 105(1):121-130. PubMed ID: 29717478
[TBL] [Abstract][Full Text] [Related]
11. Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy.
Modrego PJ; Fayed N; Errea JM; Rios C; Pina MA; Sarasa M
Eur J Neurol; 2010 Mar; 17(3):405-12. PubMed ID: 19874395
[TBL] [Abstract][Full Text] [Related]
12. Asthma and Chronic Obstructive Pulmonary Disease as a Comorbidity and Association with the Choice of Antidementia Medication Among Persons with Alzheimer's Disease.
Lampela P; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
J Alzheimers Dis; 2020; 73(3):1243-1251. PubMed ID: 31929157
[TBL] [Abstract][Full Text] [Related]
13. A Retrospective Study on the Benefits of Combined Citicoline, Memantine, and Acetylcholinesterase Inhibitor Treatments in Older Patients Affected with Alzheimer's Disease.
Castagna A; Fabbo A; Manzo C; Lacava R; Ruberto C; Ruotolo G
J Alzheimers Dis; 2021; 79(4):1509-1515. PubMed ID: 33459645
[TBL] [Abstract][Full Text] [Related]
14. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial.
Dysken MW; Sano M; Asthana S; Vertrees JE; Pallaki M; Llorente M; Love S; Schellenberg GD; McCarten JR; Malphurs J; Prieto S; Chen P; Loreck DJ; Trapp G; Bakshi RS; Mintzer JE; Heidebrink JL; Vidal-Cardona A; Arroyo LM; Cruz AR; Zachariah S; Kowall NW; Chopra MP; Craft S; Thielke S; Turvey CL; Woodman C; Monnell KA; Gordon K; Tomaska J; Segal Y; Peduzzi PN; Guarino PD
JAMA; 2014 Jan; 311(1):33-44. PubMed ID: 24381967
[TBL] [Abstract][Full Text] [Related]
15. Time to Treatment Initiation in People With Alzheimer Disease: A Meta-Analysis of Randomized Controlled Trials.
Tsoi KK; Hirai HW; Chan JY; Kwok TC
J Am Med Dir Assoc; 2016 Jan; 17(1):24-30. PubMed ID: 26392193
[TBL] [Abstract][Full Text] [Related]
16. Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer's Disease over a Three-Year Period: Kuopio ALSOVA Study.
Törmälehto SM; Martikainen JA; Väätäinen ST; Hallikainen IT; Hallikainen M; Bell JS; Koivisto AM
J Alzheimers Dis; 2015; 48(4):1033-41. PubMed ID: 26444756
[TBL] [Abstract][Full Text] [Related]
17. Current Alzheimer's disease clinical trials: methods and placebo outcomes.
Schneider LS; Sano M
Alzheimers Dement; 2009 Sep; 5(5):388-97. PubMed ID: 19751918
[TBL] [Abstract][Full Text] [Related]
18. Effect of Apolipoprotein E ɛ4 Carrier Status on Cognitive Response to Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Cheng YC; Huang YC; Liu HC
Dement Geriatr Cogn Disord; 2018; 45(5-6):335-352. PubMed ID: 30041236
[TBL] [Abstract][Full Text] [Related]
19. Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer's disease: a meta-analysis.
Glinz D; Gloy VL; Monsch AU; Kressig RW; Patel C; McCord KA; Ademi Z; Tomonaga Y; Schwenkglenks M; Bucher HC; Raatz H
Swiss Med Wkly; 2019 Jun; 149():w20093. PubMed ID: 31269225
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
